Related Experiment Video
Updated: Aug 5, 2026

Investigating the Effects of Probiotics on Pneumococcal Colonization Using an In Vitro Adherence Assay
Published on: April 28, 2014
Effects of Probiotics on Respiratory Tract Infections and Quality of Life in Children: A Large, Prospective,
Yali Zhang1, Xiaohui Li2, Jie Yuan2
1School of Public Health, Shanghai University of Traditional Chinese Medicine, Shanghai, People's Republic of China.
Insights
This study found that probiotics significantly reduced respiratory infections in children, improving their health and well-being in real-world settings. Caregivers reported fewer symptoms and medical visits, supporting probiotic use as a preventive strategy.
Area of Science:
- Pediatric Health
- Microbiome Research
- Immunology
Background:
- Respiratory tract infections (RTIs) are a significant burden in children's healthcare.
- While randomized controlled trials (RCTs) suggest probiotic benefits, real-world evidence from community settings is limited.
Purpose of the Study:
- To evaluate the impact of combined Lactobacillus rhamnosus CRL1505 and Bifidobacterium breve M-16V on respiratory and general health in children.
- To assess the effectiveness of probiotics in a large, community-based pediatric population.
Main Methods:
- A prospective, multicenter, single-arm, community-based study involving 236 children aged 0-14 years with recent RTIs.
- Children received a 4-week course of probiotics; outcomes included symptom frequency, medical visits, and quality of life (QoL) via questionnaires.
Main Results:
- Probiotic use was associated with significant reductions in cold frequency (95.34%) and medical visits (94.49%).
- Marked improvement or complete symptom disappearance was observed in 80.51% of children, with symptom relief within 1-3 days for 58.47%.
- Quality of life improved in 97.88% of children, with notable gains in appetite, energy, and sleep.
Conclusions:
- Probiotic supplementation demonstrated a reduction in RTI burden and enhanced daily well-being in a real-world pediatric cohort.
- These findings support the use of probiotics as a preventive strategy in community settings, complementing existing RCT data.
Background:
Respiratory tract infections (RTIs) are common in children and contribute substantially to healthcare burden. Although randomized controlled trials (RCTs) have shown probiotic benefits, evidence from large-scale, real-world community settings remains limited.
Objective:
This prospective, multicenter, community-based study evaluated the effects of combined Lactobacillus rhamnosus CRL1505 and Bifidobacterium breve M-16V supplementation on respiratory and general health outcomes in children.
Methods:
In this prospective, multicenter, single-arm, community-based study without a placebo control group, 236 children aged 0-14 years with a recent history of RTIs received a 4-week probiotic course and were included in the per-protocol analysis. Symptom frequency, medical visits, and caregiver-reported quality of life (QoL) were assessed through structured questionnaires.
Results:
At baseline, rhinorrhea (51.7%), cough (43.2%), and allergic manifestations (47.0%) were common. After four weeks of probiotic intake, 95.34% of guardians reported that probiotic use was associated with reduced cold frequency (p < 0.001 vs null), and 94.49% observed fewer medical visits (p < 0.001). Complete symptom disappearance occurred in 22.88% of children, while 57.63% showed marked improvement. Symptom relief occurred within 1-3 days in 58.47% of cases. Quality of life improved in 97.88% of children, including better appetite/digestion (32.63%), greater energy (31.78%), and improved sleep quality (30.93%). Gastrointestinal comfort improvement was significantly higher in children <3 years (p = 0.039). No discontinuations due to adverse events were reported. Product palatability was rated "Excellent" or "Good" by 83.05% of respondents, and 99.15% of caregivers were willing to recommend it.
Conclusion:
In this large, real-world pediatric population, probiotic supplementation was associated with caregiver-reported reductions in RTI burden and improvements in daily well-being. These findings complement prior RCTs and support probiotic use in community settings as a preventive strategy.
Trial Registration:
ChiCTR2500102509.
Related Concept Videos
Probiotics
Microbiota of the Respiratory Tract
Development of Human Microbiota
Microbiota Modulation by Antibiotics
Introduction to the Human Microbiota
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
